0001179110-19-001905.txt : 20190214
0001179110-19-001905.hdr.sgml : 20190214
20190214162654
ACCESSION NUMBER: 0001179110-19-001905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190212
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carvajal Alejandra
CENTRAL INDEX KEY: 0001645755
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 19606914
MAIL ADDRESS:
STREET 1: C/O CERULEAN PHARMA INC.
STREET 2: 840 MEMORIAL DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2019-02-12
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001645755
Carvajal Alejandra
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Legal Officer
Common Stock
2019-02-12
4
M
0
10000
A
18749
D
Common Stock
2019-02-13
4
S
0
2938
12.70
D
15811
D
Restricted Stock Units
2019-02-12
4
M
0
10000
0
D
Common Stock
10000
10000
D
Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Restricted Stock Units convert into common stock on a one-for-one basis.
Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
/s/ R. Mark Chamberlin as attorney in fact
2019-02-14